Coagulopathy in COVID-19: A Systematic Review
Sharleen Winata,Andree Kurniawan +1 more
- 16 Apr 2021
- Vol. 8, Iss: 2, pp 72-80
TL;DR: Coagulopathy plays a big role to determine the prognosis of COVID-19 patients, and treatment with Low Molecular Weight Heparin (LMWH) effective to reduced 28-day mortality in patients with SIC ≥ 4 and D-dimer > six-fold of the upper limit of normal.
read more
Abstract: Introduction : Corona Virus Disease 2019 (COVID-19) firstly appeared in Wuhan, China in December 2019 and defined as a pandemic in March 2020. COVID-19 divided into asymptomatic, mild, and severe symptoms. Coagulopathy may have happened in severe COVID-19 infection, it was also associated with high mortality in COVID-19 patients. Laboratory examination is the main protocol to identify coagulopathy, thereby it also determined the prognosis of COVID-19 patients with coagulopathy. Here, we review the current evidence describing the mechanism, diagnosis, treatment, and mortality of coagulopathy in COVID-19. Method : We identify 8 studies and/or review articles evaluating coagulopathy in COVID-19 patients by searching PubMed and EMBASE databases. Results: DIC is most commonly found in death with COVID-19, the risk of VTE also higher in severe COVID-19 because of immobility and long-term bed rest. Sepsis-induced DIC is associated with organ dysfunction as in the patient with viral infection as in COVID-19 infection. Sepsis-induce Coagulopathy (SIC) score, D-dimer, and prothrombin time (PT) measured at the time the patient classified as severe COVID-19. Higher D-dimer and FDP levels, longer PT and activated partial thromboplastin time (APTT) may have a poor prognosis. Treatment with Low Molecular Weight Heparin (LMWH) effective to reduced 28-day mortality in patients with SIC ≥ 4 and D-dimer > six-fold of the upper limit of normal. Conclusion: Coagulopathy plays a big role to determine the prognosis of COVID-19 patients. Treatment with LMWH may give some benefits to COVID-19 patients.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
- 01 Jan 2020
TL;DR: Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.
12.5K
Machine Learning Sensors for Diagnosis of COVID-19 Disease Using Routine Blood Values for Internet of Things Application
Andrei Velichko,Mehmet Tahir Huyut,Maksim Belyaev,Y A Izotov,Dmitry Korzun +4 more
- 08 Sep 2022
TL;DR: This study provides a fast, reliable and cost-effective alternative tool for the diagnosis of COVID-19 based on the routine blood values measured at admission, and proposes to use these 11 features and their binary combinations as important biomarkers for ML sensors in thediagnosis of the disease, supporting edge computing on Arduino and cloud IoT service.
Severe Postpartum Hemorrhage in an Asymptomatic COVID-19 Patient: A Call to Be on Guard.
TL;DR: In this paper, a 23-year-old gravida 2 para 1 woman who was COVID-19 positive but asymptomatic presented to the obstetric department with labor pains which progressed to severe postpartum hemorrhage and development of mild respiratory distress.
Analysis of Deaths and Favorable Developments of Patients with SARS-CoV-2 Hospitalized in the Largest Hospital for Infectious Diseases and Pneumo-Phthisiology in the West of the Country
Ruxandra Laza,Cristina Dragomir,Virgil Musta,Voichita Lazureanu,Narcisa Nicolescu,Adelina Raluca Marinescu,Roxana Paczeyka,Tamara Mirela Porosnicu,Valerica Bica-Porfir,S. Laitin,Ionu Dragomir,Constantin Ilie,Luminiţa Bădiţoiu +12 more
TL;DR: Knowledge of the predictors of death in hospitalized patients allows for the future optimization of triage and therapeutic case management for COVID-19.
1
References
Platelet “First Responders” in Wound Response, Cancer, and Metastasis
David G. Menter,Scott Kopetz,Ernest T. Hawk,Anil K. Sood,Jonathan M. Loree,Paolo Gresele,Kenneth V. Honn +6 more
TL;DR: The complex interactions and the “first responder” role of platelets during diverse physiologic stresses provide a useful therapeutic target that deserves further exploration.
Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis.
TL;DR: In this paper, a meta-analysis showed that tocilizumab treatment is associated with reduction of mortality rate from COVID-19 infection and increased the length of hospital stay.
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection
TL;DR: The meta-analysis showed that metformin use is associated with reduction in mortality rate from COVID-19 infections, and patients with diabetes should be advised to continue taking met formin drugs despite CO VID-19 infection status.
The Use of ACE inhibitor/ARB in SARS-CoV-2 Patients: A Comprehensive Narrative Review
Timotius Ivan Hariyanto,Karunia Valeriani Japar,Vika Damay,Felix Kwenandar,Novia Lauren Sieto,Andree Kurniawan +5 more
TL;DR: There is still insufficient data to stop the use of ACE inhibitor/ARB in SARS-CoV-2 patients with cardiovascular comorbidity, and it is suggested that in line with the recommendations from ESC and AHA/ACC, the uses of these two drugs should still be continued.